CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0316
-0.0005 (-1.65%)
Apr 3, 2025, 2:27 PM EST
CV Sciences Employees
As of December 31, 2023, CV Sciences had 43 total employees, including 42 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.27% compared to the previous year.
Employees
43
Change (1Y)
-1
Growth (1Y)
-2.27%
Revenue / Employee
$327,188
Profits / Employee
-$49,875
Market Cap
5.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
CV Sciences News
- 7 days ago - CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results - Accesswire
- 8 days ago - CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods - Accesswire
- 13 days ago - Cannabis Stock Gainers And Losers From March 21, 2025 - Benzinga
- 14 days ago - CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025 - Accesswire
- 20 days ago - Marijuana Stock Movers For March 14, 2025 - Benzinga
- 2 months ago - CV Sciences Unveils New Aura Collection THC Fizz Tablets - Accesswire
- 4 months ago - CV Sciences enters into agreement to acquire Extract Labs - Seeking Alpha